Table 3.
Group | Cases | FMAUE before treatment | FMAUE after treatment | t | P |
---|---|---|---|---|---|
Control group | 60 | 24.30 ± 4.15 | 27.27 ± 4.40 | 3.821 | 0.001 |
NMES group | 60 | 23.27 ± 3.28 | 30.83 ± 5.60∗a | 8.771 | 0.001 |
rTMS group | 60 | 23.40 ± 4.04 | 31.77 ± 5.83∗a | 9.032 | 0.001 |
NMES+rTMS group | 60 | 24.35 ± 4.18 | 33.80 ± 4.16∗abc | 12.44 | 0.001 |
F | 1.287 | 17.529 | |||
P | 0.280 | 0.000 |
∗ P < 0.05 vs. before treatment; aP < 0.05 vs. control group; bP < 0.05 vs. NMES group; cP < 0.05 vs. rTMS group.